I am a venture builder expert with more than 15 years of experience translating science into consumer products in the food science space. Skilled in business development, multi-function team management, innovation and IP. Wendel’s professional experience went through all stages to the launch a new science-based business, ranging from lab scale, scale-up, business modeling, venture capital investment, revenue generation and market expansion. Over the last decade he performed innumerous prototypes, clinical trials and launched more 30 successful innovative products. Such work was anchored on a solid scientific production, around 20 articles and 3 patents. His last venture placed second in the national ranking of fastest growing SME companies in Brazil (earnings growth was 179% CAGR between FY11-15 – Deloitte, 2015). The company was the only Brazilian manufacturer of human nutrition for special needs competing head-to-head with large foreign multinationals such as Danone, Nestle and Mead Johnson. MBA at MIT (Sloan School of Management) and MSc Food Science and Technology.
Did you know?
Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.
To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.
In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.
The question for Sumit Sinha and Mukesh Bansal in February 2019 was which would come first: The funding for their seed round or the sale of their Hyundai hatchbacks.
In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.
It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.
Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.
Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.